March 24, 2026

HER2CLIMB-05 Study: Tucatinib Enhances Progression-Free Survival as First-Line Maintenance for HER2-Positive Metastatic Breast Cancer

The addition of the selective HER2 inhibitor tucatinib to trastuzumab and pertuzumab as first-line maintenance therapy significantly prolonged investigator-assessed progression-free survival in patien...

The ASCO Post

March 24, 2026

How the Outlook on Fertility Preservation for Patients With Cancer Is Improving

Each year in the United States, about 90,000 adolescents and young adults (AYAs), ages 15 to 39, are diagnosed with cancer,1 and they are immediately faced with myriad challenges and disruptions in th...

The ASCO Post

March 18, 2026

AAP, NASPGHAN Issue Guidance on Faltering Weight in Children

New recommendations standardize diagnosis and aim to reduce unnecessary interventions in early childhood growth concerns.

Conexiant

March 17, 2026

ADA calls for improved interoperability standards for dental imaging 

The ADA submitted comments in response to a request for information on diagnostic imaging interoperability standards and certification. 

ADA News

March 17, 2026

Updated Guidelines for Reducing Heart Disease and Stroke Risks

Preventive cardiologist Heather Johnson, M.D., was part of the writing committee for a new, comprehensive tool for assessing and treating these health risks.

Baptist Health South Florida

March 17, 2026

Women and Liver Fibrosis Risk: New Insights

Study reveals sex-specific differences in fibrosis associations

The Pathologist

March 16, 2026

Oral Bacteria Linked to Bone Loss in Mouse Study

Researchers find periodontitis-associated microbiota altered gut metabolism and increased osteoclast activity in mice.

The Analytical Scientist

March 13, 2026

Female Reproductive Cancers Linked to Reduced Survival Advantage Over Males

Although females live longer than males on average, a large international study suggested that breast and gynecologic cancers reduce their total survival and advantage.

The ASCO Post

March 12, 2026

FDA Releases Updated Guidance on Biosimilar Development

The U.S. Food and Drug Administration (FDA) has released a new draft guidance to streamline the development of biosimilars, reflecting actions being taken by the agency to lower the cost of drugs.

The ASCO Post

March 12, 2026

The Oral GLP‑1 Era Has Arrived 

And chromatographers are about to be very busy…

The Analytical Scientist